In this latest article in our “Road to Industry 4.0” series, we discuss another powerful approach to improving operational excellence in industrial environments: the use of Robotic Process Automation (RPA) and associated artificial intelligence (AI) functionalities to execute high-volume, labor-intensive transactional tasks and support decision-making on the shop floor.

Exponentially increasing data volumes, a constantly growing number of apps and systems as well as increasingly complex international regulatory environments are making the fight against financial crime (FinCrime) more and more complex. By using graph analytics, the increasingly complex requirements for compliance reviews can be successfully managed, as the example (provided below) of deployment at a Swiss private bank show.

Investors have experienced a challenging year in 2023 when M&A activity was hit by concerns about the macroeconomic environment and the impact of higher interest rates.

The financial health of companies in the electric power space is critical for the energy transition, making climate resilience essential for achieving broader decarbonization goals.

This report was first published in Mealey’s Litigation Report: Artificial Intelligence.

On November 22, 2023, Chancellor Jeremy Hunt presented the UK's Autumn Budget.

After enjoying strong tailwinds over the past decade, private markets players have had to navigate a very different environment in 2023. This year will likely be remembered for the slowdown in buyouts, depressed exit activity and fundraising pressures that have followed the new macroeconomic reality of higher interest rates, rising inflation and slower growth.

In Part 2 of this series, A&M Director Ben Wilson explores the innovative use of Combinatorial Clock Acquisitions (CCAs), showcasing their unparalleled ability to streamline government procurement processes and amplify efficiency. 

Against a backdrop of prevailing macroeconomic headwinds, including high energy prices, constrained global supply chains and a 40-year high inflation rate, the MedTech industry has continued to demonstrate resilience with revenues forecasted to increase by 4.2% from 2022. In contrast, the UK’s GDP is only expected to grow 0.6% in 2023. MedTech’s and indeed the broader Healthcare and Life Sciences sector’s superior growth is being driven by key trends.

Accelerated M&A process and solvent sale of the Group’s main trading subsidiary to Universal Matter Inc.

Accelerated M&A process and solvent sale of the Group’s main trading subsidiary to Universal Matter Inc.